{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:21:57Z","timestamp":1790709717443,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The optimal revascularization approach for intermediate- and high-risk individuals with severe aortic stenosis (AS) and concomitant coronary artery disease (CAD) remains uncertain, particularly regarding the comparative short- and mid- to long-term outcomes of transcatheter aortic valve replacement with percutaneous coronary intervention (TAVR\u2009+\u2009PCI) vs. surgical aortic valve replacement with coronary artery bypass grafting (SAVR\u2009+\u2009CABG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of major databases was conducted up to March 2025 to identify studies comparing TAVR\u2009+\u2009PCI vs. SAVR\u2009+\u2009CABG in this population. Meta-analyses were performed using a random-effects model to estimate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Evidence quality was assessed using the GRADE framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen studies comprising 53,869 patients were analyzed. Compared with SAVR\u2009+\u2009CABG, TAVR\u2009+\u2009PCI was associated with lower 30-day risks of stroke, myocardial infarction, and acute kidney injury, but higher permanent pacemaker implantation. No differences were found in all-cause mortality, major vascular complications, or major bleeding. In mid- to long-term follow-up (\u22652 years), the TAVR\u2009+\u2009PCI group exhibited increased risks of all-cause mortality, myocardial infarction, and repeat revascularization, with similar stroke rates between strategies. Certainty of evidence ranged from very low to moderate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In intermediate- and high-risk patients with severe AS and concomitant CAD, TAVR\u2009+\u2009PCI appears to confer short-term safety advantages but may be associated with less favorable mid- to long-term outcomes compared with SAVR\u2009+\u2009CABG. These findings support individualized revascularization strategies that balance early procedural safety against longer-term risks and highlight the need for further randomized trials with extended follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251000317<\/jats:ext-link>\n                      , PROSPERO CRD420251000317.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1640906","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:41:50Z","timestamp":1769755310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing TAVR\u2009+\u2009PCI vs. SAVR\u2009+\u2009CABG across short- and mid- to long-term horizons in patients with severe aortic stenosis and concomitant CAD: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiang","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Dazhou Second People\u2019s Hospital","place":["Dazhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuge","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Dazhou Second People\u2019s Hospital","place":["Dazhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dazhou Second People\u2019s Hospital","place":["Dazhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghong","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dazhou Second People\u2019s Hospital","place":["Dazhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dazhou Second People\u2019s Hospital","place":["Dazhou, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","article-title":"Global epidemiology of valvular heart disease","volume":"18","author":"Coffey","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamacardio.2022.2695","article-title":"Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial","volume":"7","author":"Van Mieghem","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2019.06.012","article-title":"Coronary artery disease and transcatheter aortic valve replacement: jACC state-of-the-art review","volume":"74","author":"Faroux","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/ccd.27440","article-title":"Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: real-world results from the east Denmark heart registry","volume":"92","author":"Millan-Iturbe","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/j.jtcvs.2021.04.002","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"162","author":"Otto","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.jcin.2020.07.009","article-title":"Procedural characteristics and late outcomes of percutaneous coronary intervention in the workup Pre-TAVR","volume":"13","author":"Faroux","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(23)02754-X","article-title":"The future of valvular heart disease assessment and therapy","volume":"403","author":"Sengupta","year":"2024","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.athoracsur.2021.08.028","article-title":"Aortic stenosis and coronary artery disease: cost of transcatheter vs surgical management","volume":"114","author":"Patlolla","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.amjcard.2020.09.040","article-title":"Outcomes of transcatheter aortic valve replacement with percutaneous coronary intervention versus surgical aortic valve replacement with coronary artery bypass grafting","volume":"137","author":"Abugroun","year":"2020","journal-title":"Am J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ejcts\/ezu339","article-title":"Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach\u2020","volume":"47","author":"Penkalla","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.jcin.2021.06.041","article-title":"ACTIVATION (Percutaneous coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial","volume":"14","author":"Patterson","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jtcvs.2022.08.006","article-title":"Complete transcatheter versus surgical approach stenosis with coronary artery disease: a systematic and meta-analysis","volume":"167","author":"Sakurai","year":"2024","journal-title":"Jo Thorac Cardiovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/02676591231178894","article-title":"Percutaneous versus surgical approach to aortic valve replacement with coronary revascularization: a systematic review andmeta-analysis","volume":"39","author":"Guo","year":"2024","journal-title":"Perfusion"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/jocs.14814","article-title":"Coronary revascularization during treatment of severe aortic stenosis: a meta-analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical approach (CABG plus SAVR)","volume":"35","author":"Tarus","year":"2020","journal-title":"J Card Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/ccd.29110","article-title":"Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: a systematic review and meta-analysis","volume":"96","author":"Kotronias","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2020.06.024","article-title":"Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: a systematic review and meta-analysis","volume":"308","author":"Zhang","year":"2020","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/ccd.31697","article-title":"Transcatheter versus surgical approach for the treatment of aortic stenosis in patients with concomitant coronary artery disease: a systematic review and meta-analysis","volume":"106","author":"Bacha","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.hrtlng.2025.09.018","article-title":"Transcatheter versus surgical treatment in aortic stenosis with coronary artery disease: a meta-analysis of time-to-event data on 162,305 patients","volume":"75","author":"Emara","year":"2026","journal-title":"Heart Lung"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"B23","author":"Wells","year":"2011"},{"key":"B24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE Guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1055\/a-2493-1495","article-title":"Renal function after combined treatment for coronary disease and aortic valve replacement","volume":"3","author":"Taghiyev","year":"2025","journal-title":"Thorac Cardiovasc Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/S0140-6736(24)02100-7","article-title":"Transcatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial","volume":"404","author":"Kedhi","year":"2025","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.athoracsur.2024.12.016","article-title":"Transcatheter vs surgical aortic valve replacement in medicare beneficiaries with aortic stenosis and coronary artery disease","volume":"119","author":"Jagadeesan","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.jcin.2024.09.003","article-title":"Surgical vs transcatheter treatment in patients with coronary artery disease and severe aortic stenosis","volume":"17","author":"Amat-Santos","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ccd.30832","article-title":"Trends and outcomes of combined percutaneous (TAVI plus PCI) and surgical approach (SAVR plus CABG) for patients with aortic valve and coronary artery disease: a national readmission database (NRD) analysis","volume":"102","author":"Ullah","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.recesp.2022.12.011","article-title":"In-hospital outcomes following percutaneous versus surgical intervention in the treatment of aortic stenosis and concomitant coronary artery disease","volume":"76","author":"McInerney","year":"2023","journal-title":"Rev Esp Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.acvd.2022.12.004","article-title":"Catheter versus surgical approach for the management of concomitant aortic stenosis and coronary artery disease: an inverse probability treatment weighting analysis","volume":"116","author":"L\u00e9rault","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1055\/a-2003-2105","article-title":"Surgical versus interventional treatment of concomitant aortic valve stenosis and coronary artery disease","volume":"71","author":"Elderia","year":"2023","journal-title":"Thorac Cardiovasc Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.jcin.2021.08.073","article-title":"Transcatheter versus surgical aortic valve replacement in patients with complex coronary artery disease","volume":"14","author":"Alperi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/CIRCULATIONAHA.118.039564","article-title":"Comparison of a complete percutaneous versus surgical approach to aortic valve replacement and revascularization in patients at intermediate surgical risk results from the randomized SURTAVI trial","volume":"140","author":"S\u00f8ndergaard","year":"2019","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12872-019-1087-2","article-title":"Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures","volume":"19","author":"Baumbach","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"B36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijcard.2018.06.011","article-title":"Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: a comparative analysis from the Italian OBSERVANT study","volume":"270","author":"Barbanti","year":"2018","journal-title":"Int J Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.athoracsur.2012.07.075","article-title":"Management of high-risk patients with aortic stenosis and coronary artery disease","volume":"95","author":"Wendt","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e018506","DOI":"10.1161\/JAHA.120.018506","article-title":"Degeneration of bioprosthetic heart valves: update 2020","volume":"9","author":"Kostyunin","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacc.2017.04.053","article-title":"Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI","volume":"70","author":"Auffret","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1640906\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:27:15Z","timestamp":1771925235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1640906\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2026.1640906"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1640906","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1640906"}}